Pharmaceutical patent protection and world trade law
the unresolved problem of access to medicines
| LEADER | cam a22 4 4500 | ||
|---|---|---|---|
| 001 | 528773909 | ||
| 003 | CHVBK | ||
| 005 | 20201018170112.0 | ||
| 008 | 180922s2018 xxk b||| 001 0 eng| | ||
| 010 | |a 2018000566 | ||
| 020 | |a 978-1-138-28876-8 |q hbk | ||
| 020 | |a 978-0-367-59091-8 |q pbk | ||
| 020 | |z 978-1-315-26769-2 |q ebk | ||
| 020 | |z 978-1-351-97383-0 |q web PDF | ||
| 020 | |z 978-1-351-97382-3 |q ePUB | ||
| 020 | |z 978-1-351-97381-6 |q Mobipocket/Kindle | ||
| 035 | |a (NEBIS)011120143 | ||
| 035 | |a (IDSBB)006801587 | ||
| 035 | |a (RERO)R008863944 | ||
| 035 | |a (OCoLC)1019837054 | ||
| 040 | |a DLC |b ger |d SzZuIDS NEBIS ZBZ |e rda | ||
| 050 | 0 | 0 | |a K1519.D78 |b S86 2018 |
| 060 | 0 | 0 | |a 2018 F-539 |
| 072 | 7 | |a s1dr |2 rero | |
| 082 | 0 | 0 | |a 346.04/86 |2 23 |
| 082 | 1 | |a 340 |2 15 | |
| 100 | 1 | |a Sundaram |D Jae |0 (DE-588)1158638566 |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Pharmaceutical patent protection and world trade law |b the unresolved problem of access to medicines |c Jae Sundaram |
| 264 | 1 | |a London |b Routledge |c 2018 | |
| 300 | |a xvi, 240 Seiten | ||
| 490 | 0 | |a Routledge research in intellectual property | |
| 500 | |a Hier auch später erschienene, unveränderte Nachdrucke | ||
| 504 | |a Includes bibliographical references and index | ||
| 650 | 0 | |a QV 736.1 | |
| 650 | 2 | |a Patents as Topic |x legislation & jurisprudence |0 (DNLM)D010330Q000331 | |
| 650 | 7 | |a COMMERCIAL LAW |x eng |0 (ETHUDK)000011450 |2 ethudk | |
| 650 | 7 | |a DRUGS + PHARMACEUTICAL PRODUCTS |x eng |0 (ETHUDK)000026662 |2 ethudk | |
| 650 | 7 | |a FOREIGN TRADE AGREEMENTS |x eng |0 (ETHUDK)000010909 |2 ethudk | |
| 650 | 7 | |a PATENT PROTECTION + INVENTION PROTECTION (PATENT LAW, TRADEMARK LAW) |x eng |0 (ETHUDK)000060973 |2 ethudk | |
| 650 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd | |
| 650 | 7 | |a Arzneimittelversorgung |0 (DE-588)4140783-0 |2 gnd | |
| 650 | 7 | |a Internationales Wirtschaftsrecht |0 (DE-588)4027461-5 |2 gnd | |
| 650 | 7 | |a Medizinische Ethik |0 (DE-588)4074672-0 |2 gnd | |
| 650 | 7 | |a Patentrecht |0 (DE-588)4044884-8 |2 gnd | |
| 650 | 7 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |2 gnd | |
| 650 | 0 | |a Drugs |v Patents | |
| 650 | 0 | |a Drug accessibility | |
| 650 | 0 | |a Patent laws and legislation | |
| 650 | 0 | |a Foreign trade regulation | |
| 650 | 0 | |a Pharmaceutical industry |x Moral and ethical aspects | |
| 650 | 7 | |a Patentschutz |0 (DE-588)4173537-7 |2 gnd | |
| 691 | 7 | |B u |a DRUGS + PHARMACEUTICAL PRODUCTS |z eng |u 615.2/.3 |2 nebis E1 | |
| 691 | 7 | |B u |a PATENT PROTECTION + INVENTION PROTECTION (PATENT LAW, TRADEMARK LAW) |z eng |u 347.77,12 |2 nebis E1 | |
| 691 | 7 | |B u |a COMMERCIAL LAW |z eng |u 347.7 |2 nebis E1 | |
| 691 | 7 | |B u |a FOREIGN TRADE AGREEMENTS |z eng |u 339,025.5 |2 nebis E1 | |
| 691 | 7 | |B u |a ARZNEIMITTEL + PHARMAZEUTISCHE PRÄPARATE |z ger |u 615.2/.3 |2 nebis E1 | |
| 691 | 7 | |B u |a MÉDICAMENTS + PRÉPARATIONS PHARMACEUTIQUES |z fre |u 615.2/.3 |2 nebis E1 | |
| 691 | 7 | |B u |a PATENTSCHUTZ + ERFINDUNGSSCHUTZ (PATENT-, MARKENRECHT) |z ger |u 347.77,12 |2 nebis E1 | |
| 691 | 7 | |B u |a PROTECTION DES BREVETS + PROTECTION DES INVENTIONS (DROIT DES BREVETS ET DES MARQUES) |z fre |u 347.77,12 |2 nebis E1 | |
| 691 | 7 | |B u |a HANDELSRECHT |z ger |u 347.7 |2 nebis E1 | |
| 691 | 7 | |B u |a DROIT COMMERCIAL |z fre |u 347.7 |2 nebis E1 | |
| 691 | 7 | |B u |a AUSSENHANDELSVERTRÄGE |z ger |u 339,025.5 |2 nebis E1 | |
| 691 | 7 | |B u |a ACCORDS DU COMMERCE EXTÉRIEUR |z fre |u 339,025.5 |2 nebis E1 | |
| 691 | 7 | |2 rero dr-sys |u A 58.2 h | |
| 691 | 7 | |2 rero dr-sys |u D 30 h | |
| 691 | 7 | |2 rero dr-sys |u D 26 h | |
| 691 | 7 | |2 rero dr-sys |u D 18 h | |
| 691 | 7 | |2 rero dr-sys |u D 35 h | |
| 898 | |a BK020000 |b XK020000 |c XK020000 | ||
| 909 | 7 | |a zbzmon201805f |c lire |d zbzswk201807b |e bruu |2 idszbz Z2 | |
| 909 | 7 | |a Stoppsignal FRED |x 20.09.2018 |2 nebis DS | |
| 912 | 7 | |a 172 |2 E01-20180827 | |
| 912 | 7 | |a 134 |2 E01-20180827 | |
| 949 | |B RERO |F RE31013 |b RE31013 |c RE310130001 |j A 58.2 h SUND 2018 |s nedm 88814 | ||
| 949 | |B NEBIS |F E06 |b E06 |c E06BI |j QM 200 S957 |z hardback | ||
| 949 | |B NEBIS |F E06 |b E06 |c E06BI |j QM 200 S957+1 |z paperback | ||
| 949 | |B NEBIS |F Z01 |b Z01 |c 02 |j 2018 A 26349 | ||
| 949 | |B IDSBB |F A100 |b A100 |c 100FM |j UBH ni 32761 |x NELA1001807 | ||
| 950 | |B NEBIS |P 100 |E 1- |a Sundaram |D Jae |0 (DE-588)1158638566 |e Verfasser |4 aut | ||
| 950 | |B NEBIS |P 490 |E 0- |a Routledge research in intellectual property | ||
| 950 | |B IDSBB |P 100 |E 1- |a Sundaram |D Jae |0 (DE-588)1158638566 |e Verfasser |4 aut | ||
| 950 | |B IDSBB |P 490 |E 0- |a Routledge research in intellectual property | ||
| 950 | |B RERO |P 100 |E 1- |a Sundaram |D Jae |4 aut | ||
| 950 | |B RERO |P 490 |E 0- |a Routledge research in intellectual property | ||
| 956 | 4 | |B NEBIS |C ZAD50 |D EBI01 |a Z01 |u https://opac.nebis.ch/objects/pdf03/z01_978-1-138-28876-8_01.pdf |y Titelblatt und Inhaltsverzeichnis |x VIEW |q pdf | |
| 956 | 4 | |B IDSBB |C DSV51 |D DSV01 |a A100 |u http://www.ub.unibas.ch/tox/IDSBB/006801587/PDF |q pdf |x VIEW |y Inhaltsverzeichnis | |
| 986 | |a SWISSBIB |b 528773909 | ||